🔎 Trials Near Me

Home › Metastatic Cancer › California › Sacramento

Pag-aaral pangklinika para sa Metastatic Cancer sa Sacramento, CA

16 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Sacramento (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Nagre-recruitPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05372614

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
  • University of California, Davis Medical Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Nagre-recruitPhase 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
Edad 12 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3
  • University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

Nagre-recruitPhase 1
  • The University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06389123

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Nagre-recruitPhase 1
  • University of California (UC) Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Nagre-recruitPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT07189195

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Nagre-recruitPhase 3
  • Sutter Institute for Medical Research, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06216301

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Nagre-recruitPhase 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Nagre-recruitPhase 1
  • University of California Davis, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT06917079

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Nagre-recruitPhase 1/2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT05384626

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Nagre-recruitPhase 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2026 · NCT06521554

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Nagre-recruitPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT06778863

Pag-aaral para sa Metastatic Cancer sa ibang lungsod

Iba pang pag-aaral sa Sacramento

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.